| Year |
Citation |
Score |
| 2023 |
Jellinger KA. Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia. Journal of Neural Transmission (Vienna, Austria : 1996). 130: 891-904. PMID 37306790 DOI: 10.1007/s00702-023-02660-3 |
0.354 |
|
| 2022 |
Nelson PT, Lee EB, Cykowski MD, Alafuzoff I, Arfanakis K, Attems J, Brayne C, Corrada MM, Dugger BN, Flanagan ME, Ghetti B, Grinberg LT, Grossman M, Grothe MJ, Halliday GM, ... ... Jellinger K, et al. LATE-NC staging in routine neuropathologic diagnosis: an update. Acta Neuropathologica. PMID 36512061 DOI: 10.1007/s00401-022-02524-2 |
0.536 |
|
| 2022 |
Jellinger KA. Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies? Parkinsonism & Related Disorders. 100: 24-32. PMID 35691178 DOI: 10.1016/j.parkreldis.2022.05.024 |
0.326 |
|
| 2022 |
Jellinger KA. Heterogeneity of Multiple System Atrophy: An Update. Biomedicines. 10. PMID 35327402 DOI: 10.3390/biomedicines10030599 |
0.312 |
|
| 2021 |
Jellinger KA. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases. Journal of Neural Transmission (Vienna, Austria : 1996). 128: 687-699. PMID 33928445 DOI: 10.1007/s00702-021-02345-9 |
0.388 |
|
| 2021 |
Jellinger KA. Morphological differences between dementia with Lewy bodies and Parkinson's disease-dementia. Neuropathology and Applied Neurobiology. PMID 33735473 DOI: 10.1111/nan.12708 |
0.355 |
|
| 2021 |
Jellinger KA. Pathobiological Subtypes of Alzheimer Disease. Dementia and Geriatric Cognitive Disorders. 1-13. PMID 33429401 DOI: 10.1159/000508625 |
0.363 |
|
| 2021 |
Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G, Hortobagyi T, Jellinger K, Kovacs GG, Lee EB, Love S, McAleese KE, Nelson PT, Neumann M, Parkkinen L, et al. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathologica. PMID 33399945 DOI: 10.1007/s00401-020-02255-2 |
0.487 |
|
| 2020 |
Jellinger KA. Neuropathology of the Alzheimer's continuum: an update. Free Neuropathology. 1. PMID 37283686 DOI: 10.17879/freeneuropathology-2020-3050 |
0.372 |
|
| 2020 |
Jellinger KA. Neuropathological assessment of the Alzheimer spectrum. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 32740684 DOI: 10.1007/S00702-020-02232-9 |
0.467 |
|
| 2020 |
Jellinger KA. Neuropathological findings in multiple system atrophy with cognitive impairment. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 32367182 DOI: 10.1007/S00702-020-02201-2 |
0.433 |
|
| 2020 |
Jellinger KA. Striatal dopamine transporter activity may predict β-amyloid pathology in dementia with Lewy bodies. Neurology. PMID 32086383 DOI: 10.1212/Wnl.0000000000009167 |
0.425 |
|
| 2019 |
Jellinger KA. Traumatic brain injury and Alzheimer's disease neuropathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31402325 DOI: 10.1016/J.Jalz.2019.06.3917 |
0.355 |
|
| 2019 |
Jellinger KA. Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 31214855 DOI: 10.1007/S00702-019-02028-6 |
0.341 |
|
| 2019 |
Jellinger KA. Primary age-related tauopathy (PART) and Alzheimer's disease (AD). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30853463 DOI: 10.1016/J.Jalz.2019.01.005 |
0.419 |
|
| 2019 |
Jellinger KA. Parkinsonism in MCI or mild Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30827873 DOI: 10.1016/J.Jalz.2018.12.014 |
0.415 |
|
| 2018 |
Jellinger KA. Different patterns of hippocampal tau pathology in Alzheimer's disease and PART. Acta Neuropathologica. PMID 30088091 DOI: 10.1007/S00401-018-1894-Z |
0.41 |
|
| 2018 |
Jellinger KA. Very old onset parkinsonism: A clinical-pathological study. Parkinsonism & Related Disorders. PMID 30054179 DOI: 10.1016/J.Parkreldis.2018.07.015 |
0.336 |
|
| 2018 |
Jellinger KA. Is Braak staging valid for all types of Parkinson's disease? Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29943229 DOI: 10.1007/S00702-018-1898-9 |
0.32 |
|
| 2018 |
Jellinger KA, Korczyn AD. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease? Bmc Medicine. 16: 34. PMID 29510692 DOI: 10.1186/S12916-018-1016-8 |
0.418 |
|
| 2018 |
Attems J, Jellinger K. Proteomics for synaptic markers of cognitive decline in neurodegenerative diseases. Brain : a Journal of Neurology. 141: 329-331. PMID 29390123 DOI: 10.1093/Brain/Awx360 |
0.534 |
|
| 2017 |
Jellinger KA. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29222591 DOI: 10.1007/S00702-017-1821-9 |
0.452 |
|
| 2017 |
Jellinger KA. Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy. Journal of Alzheimer's Disease : Jad. PMID 28984582 DOI: 10.3233/Jad-170397 |
0.349 |
|
| 2017 |
Riederer P, Korczyn AD, Ali SS, Bajenaru O, Choi MS, Chopp M, Dermanovic-Dobrota V, Grünblatt E, Jellinger KA, Kamal MA, Kamal W, Leszek J, Sheldrick-Michel TM, Mushtaq G, Meglic B, et al. The diabetic brain and cognition. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 28766040 DOI: 10.1007/S00702-017-1763-2 |
0.375 |
|
| 2016 |
McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Hortobagyi T, Ince P, Jellinger K, Gao J, Kalaria RN, Kovacs GG, Kövari E, Love S, Popovic M, et al. Post-mortem assessment in vascular dementia: advances and aspirations. Bmc Medicine. 14: 129. PMID 27600683 DOI: 10.1186/S12916-016-0676-5 |
0.603 |
|
| 2016 |
Jellinger KA, Logroscino G, Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A. Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis. Neurology. 87: 237-8. PMID 27402941 DOI: 10.1212/Wnl.0000000000002876 |
0.321 |
|
| 2016 |
Jellinger KA, Wenning GK. Multiple system atrophy: pathogenic mechanisms and biomarkers. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 27098666 DOI: 10.1007/S00702-016-1545-2 |
0.319 |
|
| 2015 |
Love S, Chalmers K, Ince P, Esiri M, Attems J, Kalaria R, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG. Erratum: Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. American Journal of Neurodegenerative Disease. 4: 49. PMID 26807344 |
0.504 |
|
| 2015 |
Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, ... ... Jellinger K, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica. PMID 26659578 DOI: 10.1007/S00401-015-1509-X |
0.575 |
|
| 2015 |
Jellinger KA. Neuropathobiology of non-motor symptoms in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 1429-40. PMID 25976432 DOI: 10.1007/S00702-015-1405-5 |
0.323 |
|
| 2015 |
Attems J, Walker L, Jellinger KA. Olfaction and Aging: A Mini-Review. Gerontology. PMID 25968962 DOI: 10.1159/000381619 |
0.565 |
|
| 2015 |
Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathologica. 129: 757-62. PMID 25778618 DOI: 10.1007/S00401-015-1407-2 |
0.633 |
|
| 2015 |
Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathologica. 129: 729-48. PMID 25758940 DOI: 10.1007/S00401-015-1406-3 |
0.667 |
|
| 2015 |
Kim HJ, Jeon BS, Jellinger KA. Diagnosis and differential diagnosis of MSA: boundary issues. Journal of Neurology. PMID 25663409 DOI: 10.1007/S00415-015-7654-2 |
0.343 |
|
| 2015 |
Jellinger KA. The cholinergic basal forebrain in Lewy body dementia and Alzheimer's disease. Journal of Neurology. 262: 479-80. PMID 25504308 DOI: 10.1007/S00415-014-7610-6 |
0.41 |
|
| 2015 |
Jellinger KA. Pathogenesis of mild parkinsonian signs in aging. Journal of Neurology. 262: 213. PMID 25346065 DOI: 10.1007/S00415-014-7546-X |
0.435 |
|
| 2015 |
Jellinger KA, Attems J. Challenges of multimorbidity of the aging brain: a critical update. Journal of Neural Transmission (Vienna, Austria : 1996). 122: 505-21. PMID 25091618 DOI: 10.1007/S00702-014-1288-X |
0.675 |
|
| 2015 |
Jellinger KA. Neuropathology and pathogenesis of multiple system atrophy: An update Journal of Alzheimers Disease & Parkinsonism. DOI: 10.4172/2161-0460.S1.013 |
0.37 |
|
| 2015 |
Jellinger KA. The Diabetic Brain and Dementia Journal of Alzheimer’S Disease & Parkinsonism. 5. DOI: 10.4172/2161-0460.1000193 |
0.426 |
|
| 2015 |
Jellinger KA. Cognitive Impairment and the Diabetic Brain International Journal of Neurology and Neurotherapy. 2. DOI: 10.23937/2378-3001/2/2/1033 |
0.339 |
|
| 2015 |
Jellinger KA. Pathogenesis of Multiple System Atrophy - Recent Developments International Journal of Neurology and Neurotherapy. 2. DOI: 10.23937/2378-3001/2/1/1022 |
0.351 |
|
| 2015 |
Lixie E, Edgeworth J, Shamir L, Blauw GJ, Narici MV, Meskers CGM, Reijnierse EM, Maier AB, Leter MJ, Trappenburg MC, Sipilä S, Sillanpää E, Hogrel J, Butler-Browne G, Schueren MAEdvd, ... ... Jellinger KA, et al. Contents Vol. 61, 2015 Gerontology. 61. DOI: 10.1159/000440820 |
0.451 |
|
| 2014 |
Jellinger KA. Pathogenesis and treatment of vascular cognitive impairment. Neurodegenerative Disease Management. 4: 471-90. PMID 25531689 DOI: 10.2217/Nmt.14.37 |
0.341 |
|
| 2014 |
Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer's disease--lessons from pathology. Bmc Medicine. 12: 206. PMID 25385447 DOI: 10.1186/S12916-014-0206-2 |
0.683 |
|
| 2014 |
Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, ... ... Jellinger K, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathologica. 128: 755-66. PMID 25348064 DOI: 10.1007/S00401-014-1349-0 |
0.678 |
|
| 2014 |
Jellinger KA. Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1720-41. PMID 25297524 DOI: 10.1002/Mds.26052 |
0.328 |
|
| 2014 |
Krismer F, Jellinger KA, Scholz SW, Seppi K, Stefanova N, Antonini A, Poewe W, Wenning GK. Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies. Parkinsonism & Related Disorders. 20: 793-9. PMID 24894118 DOI: 10.1016/J.Parkreldis.2014.05.005 |
0.337 |
|
| 2014 |
Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. American Journal of Neurodegenerative Disease. 3: 19-32. PMID 24754000 |
0.504 |
|
| 2014 |
Sachdev P, Kalaria R, O'Brien J, Skoog I, Alladi S, Black SE, Blacker D, Blazer DG, Chen C, Chui H, Ganguli M, Jellinger K, Jeste DV, Pasquier F, Paulsen J, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Disease and Associated Disorders. 28: 206-18. PMID 24632990 DOI: 10.1097/Wad.0000000000000034 |
0.318 |
|
| 2014 |
Kuzdas-Wood D, Stefanova N, Jellinger KA, Seppi K, Schlossmacher MG, Poewe W, Wenning GK. Towards translational therapies for multiple system atrophy. Progress in Neurobiology. 118: 19-35. PMID 24598411 DOI: 10.1016/J.Pneurobio.2014.02.007 |
0.315 |
|
| 2014 |
Jellinger KA. Is there cerebellar pathology in essential tremor? Movement Disorders : Official Journal of the Movement Disorder Society. 29: 435-6. PMID 24585416 DOI: 10.1002/Mds.25852 |
0.323 |
|
| 2014 |
Attems J, Walker L, Jellinger KA. Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathologica. 127: 459-75. PMID 24554308 DOI: 10.1007/S00401-014-1261-7 |
0.618 |
|
| 2014 |
Attems J, Walker L, Jellinger KA. O4-09-05: OLFACTORY NEURODEGENERATIVE PATHOLOGY IN NEURODEGENERATIVE DISEASE Alzheimer's & Dementia. 10: P270-P270. DOI: 10.1016/J.Jalz.2014.04.437 |
0.565 |
|
| 2013 |
Attems J, Jellinger KA. Amyloid and tau: neither chicken nor egg but two partners in crime! Acta Neuropathologica. 126: 619-21. PMID 23955601 DOI: 10.1007/S00401-013-1167-9 |
0.586 |
|
| 2013 |
Nelson PT, Smith CD, Abner EL, Wilfred BJ, Wang WX, Neltner JH, Baker M, Fardo DW, Kryscio RJ, Scheff SW, Jicha GA, Jellinger KA, Van Eldik LJ, Schmitt FA. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathologica. 126: 161-77. PMID 23864344 DOI: 10.1007/S00401-013-1154-1 |
0.421 |
|
| 2013 |
Rauramaa T, Pikkarainen M, Englund E, Ince PG, Jellinger K, Paetau A, Alafuzoff I. Consensus recommendations on pathologic changes in the hippocampus: a postmortem multicenter inter-rater study. Journal of Neuropathology and Experimental Neurology. 72: 452-61. PMID 23656988 DOI: 10.1097/Nen.0B013E318292492A |
0.354 |
|
| 2013 |
Attems J, Jellinger K. Neuropathological correlates of cerebral multimorbidity. Current Alzheimer Research. 10: 569-77. PMID 23627751 DOI: 10.2174/15672050113109990002 |
0.651 |
|
| 2013 |
Jellinger KA, Attems J. Neuropathological approaches to cerebral aging and neuroplasticity. Dialogues in Clinical Neuroscience. 15: 29-43. PMID 23576887 |
0.562 |
|
| 2013 |
Jellinger KA. Organic bases of late-life depression: a critical update. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 1109-25. PMID 23355089 DOI: 10.1007/S00702-012-0945-1 |
0.406 |
|
| 2013 |
McAleese KE, Firbank M, Hunter D, Sun L, Hall R, Neal JW, Mann DM, Esiri M, Jellinger KA, O'Brien JT, Attems J. Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter. Neuropathology and Applied Neurobiology. 39: 485-97. PMID 23075072 DOI: 10.1111/J.1365-2990.2012.01310.X |
0.581 |
|
| 2013 |
Jellinger KA. Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 157-67. PMID 22350538 DOI: 10.1007/S00702-012-0771-5 |
0.33 |
|
| 2012 |
Jellinger KA, Attems J. Nigral pathology in older persons without Parkinson disease. Annals of Neurology. 72: 297; author reply 29. PMID 22926864 DOI: 10.1002/Ana.23640 |
0.552 |
|
| 2012 |
Attems J, Thal DR, Jellinger KA. The relationship between subcortical tau pathology and Alzheimer's disease. Biochemical Society Transactions. 40: 711-5. PMID 22817721 DOI: 10.1042/Bst20120034 |
0.665 |
|
| 2012 |
Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Englund E, Ferrer I, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, ... ... Jellinger K, et al. The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium. Experimental Gerontology. 47: 825-33. PMID 22705312 DOI: 10.1016/J.Exger.2012.06.001 |
0.578 |
|
| 2012 |
Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, ... ... Jellinger KA, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of Neuropathology and Experimental Neurology. 71: 362-81. PMID 22487856 DOI: 10.1097/Nen.0B013E31825018F7 |
0.308 |
|
| 2012 |
Jellinger KA, Attems J. Neuropathology and general autopsy findings in nondemented aged subjects. Clinical Neuropathology. 31: 87-98. PMID 22385790 DOI: 10.5414/Np300418 |
0.603 |
|
| 2012 |
Watabe-Rudolph M, Song Z, Lausser L, Schnack C, Begus-Nahrmann Y, Scheithauer MO, Rettinger G, Otto M, Tumani H, Thal DR, Attems J, Jellinger KA, Kestler HA, von Arnim CA, Rudolph KL. Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology. 78: 569-77. PMID 22323746 DOI: 10.1212/Wnl.0B013E318247Caa1 |
0.635 |
|
| 2012 |
Zellner M, Baureder M, Rappold E, Bugert P, Kotzailias N, Babeluk R, Baumgartner R, Attems J, Gerner C, Jellinger K, Roth E, Oehler R, Umlauf E. Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients. Journal of Proteomics. 75: 2080-92. PMID 22270014 DOI: 10.1016/J.Jprot.2012.01.014 |
0.611 |
|
| 2012 |
Jellinger KA. Interaction between pathogenic proteins in neurodegenerative disorders. Journal of Cellular and Molecular Medicine. 16: 1166-83. PMID 22176890 DOI: 10.1111/J.1582-4934.2011.01507.X |
0.33 |
|
| 2012 |
Attems J, Thomas A, Jellinger K. Correlations between cortical and subcortical tau pathology. Neuropathology and Applied Neurobiology. 38: 582-90. PMID 22115520 DOI: 10.1111/J.1365-2990.2011.01244.X |
0.675 |
|
| 2012 |
Perju-Dumbrava LD, Kovacs GG, Pirker S, Jellinger K, Hoffmann M, Asenbaum S, Pirker W. Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 65-71. PMID 22102521 DOI: 10.1002/Mds.24000 |
0.319 |
|
| 2012 |
Jellinger KA. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 8-30. PMID 22081500 DOI: 10.1002/Mds.23795 |
0.353 |
|
| 2012 |
Jellinger KA. CSF biomarkers in different phenotypes of Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 455-6. PMID 22065209 DOI: 10.1007/S00702-011-0736-0 |
0.395 |
|
| 2012 |
Jellinger KA. Neuropathological subtypes of Alzheimer's disease. Acta Neuropathologica. 123: 153-4. PMID 22009303 DOI: 10.1007/S00401-011-0889-9 |
0.412 |
|
| 2012 |
Jellinger K. Heterogenous mechanisms of mild cognitive impairment in Parkinson’s disease Journal of Neural Transmission. 119: 381-382. PMID 21960008 DOI: 10.1007/S00702-011-0716-4 |
0.353 |
|
| 2012 |
Jellinger K. Unusual tau in MSA. Neuropathology. 32: 110-111. PMID 21848588 DOI: 10.1111/J.1440-1789.2011.01246.X |
0.335 |
|
| 2012 |
Jellinger KA. Cerebral correlates of psychotic syndromes in neurodegenerative diseases. Journal of Cellular and Molecular Medicine. 16: 995-1012. PMID 21418522 DOI: 10.1111/J.1582-4934.2011.01311.X |
0.402 |
|
| 2012 |
Jellinger KA. Conference Scene: A report from the World Congress on Controversies in Neurology Neurodegenerative Disease Management. 2: 255-257. DOI: 10.2217/Nmt.12.22 |
0.316 |
|
| 2011 |
Jellinger KA, Attems J. Rapidly progressing diffuse Lewy body disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2584-5; author reply. PMID 22038930 DOI: 10.1002/Mds.23976 |
0.534 |
|
| 2011 |
Jellinger KA. Complex tauopathies versus tangle predominant dementia. Acta Neuropathologica. 122: 515; author reply 51. PMID 21932121 DOI: 10.1007/S00401-011-0868-1 |
0.412 |
|
| 2011 |
Jellinger KA, Kovacs GG. Clinico-pathological correlations in neurodegeneration. Acta Neuropathologica. 122: 115-6. PMID 21713445 DOI: 10.1007/S00401-011-0853-8 |
0.437 |
|
| 2011 |
Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, Cavalieri M, Seiler S, Enzinger C, Ropele S, Erkinjuntti T, Pantoni L, Scheltens P, Fazekas F, Jellinger K. Heterogeneity in age-related white matter changes. Acta Neuropathologica. 122: 171-85. PMID 21706175 DOI: 10.1007/S00401-011-0851-X |
0.304 |
|
| 2011 |
Jellinger KA. Synuclein deposition and non-motor symptoms in Parkinson disease. Journal of the Neurological Sciences. 310: 107-11. PMID 21570091 DOI: 10.1016/J.Jns.2011.04.012 |
0.31 |
|
| 2011 |
Fellner L, Jellinger KA, Wenning GK, Stefanova N. Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts. Acta Neuropathologica. 121: 675-93. PMID 21562886 DOI: 10.1007/S00401-011-0833-Z |
0.36 |
|
| 2011 |
Jellinger KA, Attems J. Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders. Dementia and Geriatric Cognitive Disorders. 31: 309-16. PMID 21502762 DOI: 10.1159/000327360 |
0.661 |
|
| 2011 |
Casanova MF, Starkstein SE, Jellinger KA. Clinicopathological correlates of behavioral and psychological symptoms of dementia. Acta Neuropathologica. 122: 117-35. PMID 21455688 DOI: 10.1007/S00401-011-0821-3 |
0.334 |
|
| 2011 |
Paulus W, Jellinger KA. Fifty years of Acta Neuropathologica: past, present, and future. Acta Neuropathologica. 121: 569-70. PMID 21455687 DOI: 10.1007/S00401-011-0822-2 |
0.466 |
|
| 2011 |
Attems J, Ittner A, Jellinger K, Nitsch RM, Maj M, Wagner L, Götz J, Heikenwalder M. Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 737-45. PMID 21442354 DOI: 10.1007/S00702-011-0626-5 |
0.586 |
|
| 2011 |
Blasko I, Kemmler G, Jungwirth S, Wichart I, Weissgram S, Jellinger K, Tragl KH, Fischer P. Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors. Journal of Neural Transmission. 118: 663-672. PMID 21344239 DOI: 10.1007/S00702-011-0599-4 |
0.344 |
|
| 2011 |
Attems J, Jellinger K, Thal DR, Van Nostrand W. Review: sporadic cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology. 37: 75-93. PMID 20946241 DOI: 10.1111/J.1365-2990.2010.01137.X |
0.621 |
|
| 2011 |
Jellinger KA, Grazer A, Petrovic K, Ropele S, Alpi G, Kapeller P, Ströbel T, Schmidt R. Four-repeat tauopathy clinically presenting as posterior cortical atrophy: atypical corticobasal degeneration? Acta Neuropathologica. 121: 267-77. PMID 20571819 DOI: 10.1007/S00401-010-0712-Z |
0.393 |
|
| 2011 |
Attems J, Jellinger KA. Pathologic aspects of the hemorrhagic consequences of small vessel disease on the brain Cerebral Small Vessel Disease. 29-41. DOI: 10.1017/CBO9781139382694.005 |
0.542 |
|
| 2011 |
Jellinger KA. Changing concepts in Parkinson's disease The Lancet Neurology. 10: 307. DOI: 10.1016/S1474-4422(11)70064-3 |
0.362 |
|
| 2011 |
Arnim Cv, Watabe-Rudolph M, Song Z, Schnack C, Begus-Nahrmann Y, Rolyan H, Otto M, Tumani H, Thal D, Attems J, Jellinger K, Kestler H, Rudolph K. Chitinase Enzyme Activity in Cerebral Spinal Fluid is Strongly Associated with Alzheimer’s Disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.836 |
0.511 |
|
| 2011 |
Gano C, Jellinger K, Janetzky B, Kienzl E, Rattay F, Kovacs G. P1-084: Role of the nested genes ALZAS and ALZAS-1 in Alzheimer's disease Alzheimer's & Dementia. 7: S136-S137. DOI: 10.1016/J.Jalz.2011.05.363 |
0.327 |
|
| 2010 |
Jellinger KA, Attems J. Prevalence and pathology of vascular dementia in the oldest-old. Journal of Alzheimer's Disease : Jad. 21: 1283-93. PMID 21504129 DOI: 10.3233/Jad-2010-100603 |
0.657 |
|
| 2010 |
Jellinger KA. Neuropathology in Parkinson's disease with mild cognitive impairment. Acta Neuropathologica. 120: 829-30; author reply. PMID 20922398 DOI: 10.1007/S00401-010-0755-1 |
0.4 |
|
| 2010 |
Jellinger KA, Attems J. Is there pure vascular dementia in old age? Journal of the Neurological Sciences. 299: 150-4. PMID 20869729 DOI: 10.1016/J.Jns.2010.08.038 |
0.617 |
|
| 2010 |
Blasko I, Kemmler G, Jungwirth S, Wichart I, Krampla W, Weissgram S, Jellinger K, Tragl KH, Fischer P. Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease. American Journal of Geriatric Psychiatry. 18: 973-982. PMID 20808106 DOI: 10.1097/Jgp.0B013E3181Df48Be |
0.346 |
|
| 2010 |
Jellinger KA. Correspondence regarding: thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations. J Neuropathol Exp Neurol 2010;69:449-54. Journal of Neuropathology and Experimental Neurology. 69: 864; author reply 86. PMID 20683236 DOI: 10.1097/Nen.0B013E3181E99Dfb |
0.371 |
|
| 2010 |
Jellinger KA, Lantos PL. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update. Acta Neuropathologica. 119: 657-67. PMID 20309568 DOI: 10.1007/S00401-010-0672-3 |
0.323 |
|
| 2010 |
Jellinger KA, Attems J. Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathologica. 119: 421-33. PMID 20204386 DOI: 10.1007/S00401-010-0654-5 |
0.655 |
|
| 2010 |
Jellinger KA. Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases. Neuro-Degenerative Diseases. 7: 112-5. PMID 20173339 DOI: 10.1159/000285518 |
0.446 |
|
| 2010 |
Jellinger KA. Neurochemical biomarkers in the differential diagnosis of movement disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 500. PMID 20155862 DOI: 10.1002/Mds.22853 |
0.411 |
|
| 2010 |
Jellinger KA. Basic mechanisms of neurodegeneration: a critical update. Journal of Cellular and Molecular Medicine. 14: 457-87. PMID 20070435 DOI: 10.1111/J.1582-4934.2010.01010.X |
0.315 |
|
| 2010 |
Jellinger KA. Dementia diagnosis. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 18: 92; author reply 92-. PMID 20026940 DOI: 10.1097/Jgp.0B013E3181C29459 |
0.347 |
|
| 2010 |
Jellinger KA. Intrathecal levels of IL-6 in Alzheimer's disease. Journal of Neurology. 257: 142. PMID 19760348 DOI: 10.1007/S00415-009-5312-2 |
0.372 |
|
| 2009 |
Jellinger KA. Formation and development of Lewy pathology: a critical update. Journal of Neurology. 256: 270-9. PMID 19711116 DOI: 10.1007/S00415-009-5243-Y |
0.438 |
|
| 2009 |
Jellinger KA. Recent advances in our understanding of neurodegeneration. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 1111-62. PMID 19707851 DOI: 10.1007/S00702-009-0240-Y |
0.332 |
|
| 2009 |
Jellinger KA. Absence of alpha-synuclein pathology in postencephalitic parkinsonism. Acta Neuropathologica. 118: 371-9. PMID 19404653 DOI: 10.1007/S00401-009-0537-9 |
0.361 |
|
| 2009 |
Jellinger KA. Alzheimer's disease: a challenge for modern neuropathobiology. Acta Neuropathologica. 118: 1-3. PMID 19360427 DOI: 10.1007/S00401-009-0529-9 |
0.463 |
|
| 2009 |
Jellinger KA. Lewy body/alpha-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study. Acta Neuropathologica. 117: 423-7. PMID 19198857 DOI: 10.1007/S00401-009-0492-5 |
0.316 |
|
| 2009 |
Jellinger KA. Significance of brain lesions in Parkinson disease dementia and Lewy body dementia. Frontiers of Neurology and Neuroscience. 24: 114-25. PMID 19182469 DOI: 10.1159/000197890 |
0.303 |
|
| 2009 |
Jellinger KA. Rhombencephalosynapsis with and without associated malformations. Acta Neuropathologica. 117: 219. PMID 19137321 DOI: 10.1007/S00401-008-0475-Y |
0.318 |
|
| 2009 |
Jellinger KA. Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp? Acta Neuropathologica. 117: 101-10. PMID 19052757 DOI: 10.1007/S00401-008-0466-Z |
0.381 |
|
| 2009 |
Jellinger K, Attems J, Lauda F. Sporadic cerebral amyloid angiopathy—No frequent cause of spontaneous brain hemorrhage in the aged Journal of the Neurological Sciences. 283: 274. DOI: 10.1016/J.Jns.2009.02.134 |
0.59 |
|
| 2009 |
Jellinger KA, Attems J. O4-06-06: The impact of vascular and Alzheimer pathologies in Lewy body disease Alzheimer's & Dementia. 5: P163-P164. DOI: 10.1016/J.Jalz.2009.05.563 |
0.599 |
|
| 2009 |
Attems J, Grosinger-Quass M, Nitsch R, Maj M, Wagner L, Jellinger K, Heikenwalder M. O4-03-06: Calcium binding protein Secretagogin expression in wild type and transgenic tau (P301L) mice Alzheimer's & Dementia. 5: P155-P155. DOI: 10.1016/J.Jalz.2009.05.536 |
0.505 |
|
| 2009 |
Elisabeth K, Jellinger KA, Janetzky B, Attems J, Missbichler A, Stachelberger H. P4-146: New aspects of membrane breakdown in Alzheimer's disease brain Alzheimer's & Dementia. 5: P474-P474. DOI: 10.1016/J.Jalz.2009.04.814 |
0.582 |
|
| 2009 |
Maj M, Wagner L, Ilhan A, Jellinger K, Heikenwalder M, Attems J. P3-196: The four repeat tau isoform 5 represents a calcium-dependent interaction partner of secretagogin (SCGN) Alzheimer's & Dementia. 5: P400-P400. DOI: 10.1016/J.Jalz.2009.04.1070 |
0.509 |
|
| 2008 |
Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG. Multiple system atrophy: a primary oligodendrogliopathy. Annals of Neurology. 64: 239-46. PMID 18825660 DOI: 10.1002/Ana.21465 |
0.345 |
|
| 2008 |
Jellinger KA. A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathologica. 116: 1-16. PMID 18592254 DOI: 10.1007/S00401-008-0406-Y |
0.419 |
|
| 2008 |
Jellinger KA. The pathology of "vascular dementia": a critical update. Journal of Alzheimer's Disease : Jad. 14: 107-23. PMID 18525132 DOI: 10.3233/Jad-2008-14110 |
0.417 |
|
| 2008 |
Jellinger KA. Morphologic diagnosis of "vascular dementia" - a critical update. Journal of the Neurological Sciences. 270: 1-12. PMID 18455191 DOI: 10.1016/J.Jns.2008.03.006 |
0.413 |
|
| 2008 |
Jellinger KA. Striatal beta-amyloid deposition in Parkinson disease with dementia. Journal of Neuropathology and Experimental Neurology. 67: 484; author reply 48. PMID 18451728 DOI: 10.1097/Nen.0B013E3181713Cb1 |
0.423 |
|
| 2008 |
Willis M, Prokesch M, Hutter-Paier B, Windisch M, Stridsberg M, Mahata SK, Kirchmair R, Wietzorrek G, Knaus HG, Jellinger K, Humpel C, Marksteiner J. Chromogranin B and Secretogranin II in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations and in Alzheimer patients. Journal of Alzheimer's Disease : Jad. 13: 123-35. PMID 18376054 DOI: 10.3233/Jad-2008-13202 |
0.326 |
|
| 2008 |
Jellinger KA, Janetzky B, Attems J, Kienzl E. Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker? Journal of Cellular and Molecular Medicine. 12: 1094-117. PMID 18363842 DOI: 10.1111/J.1582-4934.2008.00313.X |
0.639 |
|
| 2008 |
Jellinger KA. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neuro-Degenerative Diseases. 5: 339-46. PMID 18349518 DOI: 10.1159/000121388 |
0.334 |
|
| 2008 |
Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neuro-Degenerative Diseases. 5: 118-21. PMID 18322367 DOI: 10.1159/000113679 |
0.415 |
|
| 2008 |
Jellinger KA, Attems J. Cerebral amyloid angiopathy in Lewy body disease. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 473-82. PMID 18301958 DOI: 10.1007/S00702-007-0856-8 |
0.63 |
|
| 2008 |
Attems J, Jellinger KA. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease. Neuropathology and Applied Neurobiology. 34: 466-7. PMID 18282157 DOI: 10.1111/J.1365-2990.2008.00937.X |
0.511 |
|
| 2008 |
Jellinger KA, Attems J. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathologica. 115: 427-36. PMID 18273624 DOI: 10.1007/S00401-008-0347-5 |
0.67 |
|
| 2008 |
Jellinger KA. Re: In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution. Neurology. 70: 407-8. PMID 18227426 DOI: 10.1212/01.Wnl.0000304033.82293.9A |
0.427 |
|
| 2008 |
Attems J, Lauda F, Jellinger KA. Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study. Journal of Neurology. 255: 70-6. PMID 18202817 DOI: 10.1007/S00415-008-0674-4 |
0.659 |
|
| 2008 |
Blasko I, Jungwirth S, Jellinger K, Kemmler G, Krampla W, Weissgram S, Wichart I, Tragl KH, Hinterhuber H, Fischer P. Effects of medications on plasma amyloid beta (Aβ) 42 : Longitudinal data from the VITA cohort Journal of Psychiatric Research. 42: 946-955. PMID 18155247 DOI: 10.1016/J.Jpsychires.2007.10.010 |
0.328 |
|
| 2008 |
Attems J, Preusser M, Grosinger-Quass M, Wagner L, Lintner F, Jellinger K. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease. Neuropathology and Applied Neurobiology. 34: 23-32. PMID 17961140 DOI: 10.1111/J.1365-2990.2007.00854.X |
0.631 |
|
| 2008 |
Bianco AD, Bradl M, Frischer J, Kutzelnigg A, Jellinger K, Lassmann H. Multiple sclerosis and Alzheimer's disease. Annals of Neurology. 63: 174-183. PMID 17924575 DOI: 10.1002/Ana.21240 |
0.366 |
|
| 2008 |
Blasko I, Jellinger K, Kemmler G, Krampla W, Jungwirth S, Wichart I, Tragl KH, Fischer P. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine Neurobiology of Aging. 29: 1-11. PMID 17055615 DOI: 10.1016/J.Neurobiolaging.2006.09.002 |
0.346 |
|
| 2008 |
Schmidt R, Assem-Hilger E, Benke T, Dal-Bianco P, Delazer M, Ladurner G, Jellinger K, Marksteiner J, Ransmayr G, Schmidt H, Stögmann E, Wancata J, Bancher C, Berek K, Eggers C, et al. Geschlechtsspezifische Unterschiede der Alzheimer Demenz Neuropsychiatrie. DOI: 10.5414/Nepband22001 |
0.42 |
|
| 2008 |
Ransmayr G, Katzenschlager R, Dal-Bianco P, Wenning G, Bancher C, Jellinger K, Schmidt R, Poewe W. Lewy-Körper-Demenz und ihre differentialdagnostische Abgrenzung von Alzheimerâscher Erkrankung: Ein gemeinsames Konsensus-Statement der Ãsterreichischen Alzheimer Gesellschaft (ÃAG) und der Ãsterreichischen Parkinson Gesellschaft (ÃPG) Neuropsychiatrie. DOI: 10.5414/Nepband21063 |
0.402 |
|
| 2007 |
Jellinger KA. The enigma of mixed dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 3: 40-53. PMID 19595916 DOI: 10.1016/J.Jalz.2006.09.002 |
0.449 |
|
| 2007 |
Jellinger KA, Wenning GK, Seppi K. Predictors of survival in dementia with lewy bodies and Parkinson dementia. Neuro-Degenerative Diseases. 4: 428-30. PMID 17934326 DOI: 10.1159/000107703 |
0.401 |
|
| 2007 |
Jellinger KA, Lauda F, Attems J. Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 14: 923-8. PMID 17662016 DOI: 10.1111/J.1468-1331.2007.01880.X |
0.662 |
|
| 2007 |
Jellinger KA. More frequent Lewy bodies but less frequent Alzheimer-type lesions in multiple system atrophy as compared to age-matched control brains. Acta Neuropathologica. 114: 299-303. PMID 17476513 DOI: 10.1007/S00401-007-0227-4 |
0.37 |
|
| 2007 |
Jellinger KA, Attems J. Neuropathological evaluation of mixed dementia. Journal of the Neurological Sciences. 257: 80-7. PMID 17324442 DOI: 10.1016/J.Jns.2007.01.045 |
0.621 |
|
| 2007 |
Attems J, Quass M, Jellinger KA, Lintner F. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. Journal of the Neurological Sciences. 257: 49-55. PMID 17306303 DOI: 10.1016/J.Jns.2007.01.013 |
0.664 |
|
| 2007 |
Jellinger KA. The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathologica. 113: 349-88. PMID 17285295 DOI: 10.1007/S00401-006-0185-2 |
0.415 |
|
| 2007 |
Attems J, Quass M, Gartner W, Nabokikh A, Wagner L, Steurer S, Arbes S, Lintner F, Jellinger K. Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons. Experimental Gerontology. 42: 215-22. PMID 17116382 DOI: 10.1016/J.Exger.2006.09.018 |
0.565 |
|
| 2007 |
Jellinger KA, Attems J. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathologica. 113: 107-17. PMID 17089134 DOI: 10.1007/S00401-006-0156-7 |
0.673 |
|
| 2007 |
Attems J, Quass M, Jellinger KA. Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathologica. 113: 53-62. PMID 17031655 DOI: 10.1007/S00401-006-0146-9 |
0.67 |
|
| 2007 |
Jellinger KA. 6 – Alzheimer's Disease Neurobiology of Disease. 69-82. DOI: 10.1016/B978-012088592-3/50008-6 |
0.388 |
|
| 2006 |
Jellinger KA. Commentary on "Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples". Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 169-70. PMID 19595879 DOI: 10.1016/J.Jalz.2006.03.005 |
0.45 |
|
| 2006 |
Sofic E, Sapcanin A, Tahirovic I, Gavrankapetanovic I, Jellinger K, Reynolds GP, Tatschner T, Riederer P. Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases. Journal of Neural Transmission-Supplement. 39-43. PMID 17447414 DOI: 10.1007/978-3-211-33328-0_5 |
0.372 |
|
| 2006 |
Attems J, Jellinger KA. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clinical Neuropathology. 25: 265-71. PMID 17140156 |
0.625 |
|
| 2006 |
Jellinger KA. Clinicopathological analysis of dementia disorders in the elderly--an update. Journal of Alzheimer's Disease : Jad. 9: 61-70. PMID 16914845 DOI: 10.3233/Jad-2006-9S308 |
0.48 |
|
| 2006 |
Jellinger KA, Attems J. Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathologica. 112: 253-60. PMID 16804711 DOI: 10.1007/S00401-006-0088-2 |
0.666 |
|
| 2006 |
Jellinger KA, Attems J. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism. Acta Neurologica Scandinavica. 114: 38-46. PMID 16774626 DOI: 10.1111/J.1600-0404.2006.00665.X |
0.689 |
|
| 2006 |
Jellinger KA. P25alpha immunoreactivity in multiple system atrophy and Parkinson disease. Acta Neuropathologica. 112: 112. PMID 16688462 DOI: 10.1007/S00401-006-0075-7 |
0.355 |
|
| 2006 |
Jellinger KA. Neuropathology of dementia in Parkinson's disease. Annals of Neurology. 59: 727. PMID 16566020 DOI: 10.1002/Ana.20825 |
0.404 |
|
| 2006 |
Attems J, Jellinger KA. Hippocampal sclerosis in Alzheimer disease and other dementias. Neurology. 66: 775. PMID 16534130 DOI: 10.1212/01.Wnl.0000200959.50898.26 |
0.644 |
|
| 2006 |
Völkel W, Sicilia T, Pähler A, Gsell W, Tatschner T, Jellinger K, Leblhuber F, Riederer P, Lutz WK, Götz ME. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease. Neurochemistry International. 48: 679-86. PMID 16483694 DOI: 10.1016/J.Neuint.2005.12.003 |
0.437 |
|
| 2006 |
Glatz DC, Rujescu D, Tang Y, Berendt FJ, Hartmann AM, Faltraco F, Rosenberg C, Hulette C, Jellinger K, Hampel H, Riederer P, Möller HJ, Andreadis A, Henkel K, Stamm S. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. Journal of Neurochemistry. 96: 635-44. PMID 16371011 DOI: 10.1111/J.1471-4159.2005.03552.X |
0.366 |
|
| 2006 |
Jellinger KA. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD. Parkinsonism & Related Disorders. 12: 119-20. PMID 16337163 DOI: 10.1016/J.Parkreldis.2005.09.001 |
0.41 |
|
| 2006 |
Kienzl E, Jellinger KA, Janetzky B, Attems J, Dal-Bianco P, Stachelberger H. P1-367: Nested gene and autoimmune response in Alzheimer's disease Alzheimer's & Dementia. 2: S205-S205. DOI: 10.1016/J.Jalz.2006.05.745 |
0.57 |
|
| 2006 |
Attems J, Quass M, Gartner W, Wagner L, Jellinger KA, Lintner F. P3-183: Cellular immunoreactivity of calcium-binding protein secretagogin in human hippocampus is restricted to pyramidal neurons Alzheimer's & Dementia. 2: S428-S428. DOI: 10.1016/J.Jalz.2006.05.1451 |
0.489 |
|
| 2006 |
Jellinger KA, Attems J, Quass M, Lintner F. O2-01-04: Tau and alpha-synuclein brainstem pathology in Alzheimer disease Alzheimer's & Dementia. 2: S30-S30. DOI: 10.1016/J.Jalz.2006.05.105 |
0.592 |
|
| 2006 |
Quass M, Attems J, Jellinger KA, Lintner F. O1-01-03: Alzheimer disease pathology influences the impact of cerebral amyloid angiopathy on cognitive decline Alzheimer's & Dementia. 2: S8-S8. DOI: 10.1016/J.Jalz.2006.05.036 |
0.618 |
|
| 2005 |
Attems J, König C, Huber M, Lintner F, Jellinger KA. Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. Journal of Alzheimer's Disease : Jad. 8: 57-62. PMID 16155350 DOI: 10.3233/Jad-2005-8107 |
0.648 |
|
| 2005 |
Attems J, Jellinger KA, Lintner F. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathologica. 110: 222-31. PMID 16133541 DOI: 10.1007/S00401-005-1064-Y |
0.671 |
|
| 2005 |
Jellinger KA, Seppi K, Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Movement Disorders : Official Journal of the Movement Disorder Society. 20: S29-36. PMID 16092088 DOI: 10.1002/Mds.20537 |
0.309 |
|
| 2005 |
Jellinger KA. Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). Journal of Neuropathology and Experimental Neurology. 64: 554. PMID 15977648 DOI: 10.1093/Jnen/64.6.554 |
0.4 |
|
| 2005 |
Blasko I, Kemmler G, Krampla W, Jungwirth S, Wichart I, Jellinger K, Tragl KH, Fischer P. Plasma amyloid β protein 42 in non-demented persons aged 75 years: Effects of concomitant medication and medial temporal lobe atrophy Neurobiology of Aging. 26: 1135-1143. PMID 15917096 DOI: 10.1016/J.Neurobiolaging.2005.03.006 |
0.32 |
|
| 2005 |
Attems J, Lintner F, Jellinger KA. Olfactory involvement in aging and Alzheimer's disease: an autopsy study. Journal of Alzheimer's Disease : Jad. 7: 149-57; discussion 1. PMID 15851853 DOI: 10.3233/Jad-2005-7208 |
0.652 |
|
| 2005 |
Jellinger KA, Attems J. Alzheimer pathology in the olfactory bulb. Neuropathology and Applied Neurobiology. 31: 203. PMID 15771713 DOI: 10.1111/J.1365-2990.2004.00619.X |
0.573 |
|
| 2005 |
Jellinger KA. Understanding the pathology of vascular cognitive impairment. Journal of the Neurological Sciences. 229: 57-63. PMID 15760620 DOI: 10.1016/J.Jns.2004.11.029 |
0.431 |
|
| 2005 |
Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. Journal of the Neurological Sciences. 229: 37-41. PMID 15760617 DOI: 10.1016/J.Jns.2004.11.018 |
0.677 |
|
| 2004 |
Frölich L, Götz ME, Weinmüller M, Youdim MB, Barth N, Dirr A, Gsell W, Jellinger K, Beckmann H, Riederer P. (r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 295-310. PMID 14991456 DOI: 10.1007/S00702-003-0043-5 |
0.32 |
|
| 2004 |
Lins H, Wichart I, Bancher C, Wallesch CW, Jellinger KA, Rösler N. Immunoreactivities of amyloid beta peptide((1-42)) and total tau protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 273-80. PMID 14991454 DOI: 10.1007/S00702-003-0075-X |
0.399 |
|
| 2004 |
Attems J, Lintner F, Jellinger KA. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathologica. 107: 283-91. PMID 14986026 DOI: 10.1007/S00401-004-0822-6 |
0.63 |
|
| 2004 |
Attems J, Jellinger KA. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study. Acta Neuropathologica. 107: 83-90. PMID 14655019 DOI: 10.1007/S00401-003-0796-9 |
0.665 |
|
| 2004 |
Attems J, Lintner F, Jellinger KA. O2-04-04 Relations between cerebral amyloid angiopathy and Alzheimer's disease pathology Neurobiology of Aging. 25: S39. DOI: 10.1016/S0197-4580(04)80130-1 |
0.627 |
|
| 2004 |
Attems J, Lintner F, Jellinger K. [correction] Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology (vol 107, pg 283, 2004) Acta Neuropathologica. DOI: 10.1007/S00401-004-0866-7 |
0.596 |
|
| 2003 |
Jellinger KA. Parkinson disease with old-age onset. Archives of Neurology. 60: 1814-5. PMID 14676066 DOI: 10.1001/Archneur.60.12.1814 |
0.346 |
|
| 2003 |
Jellinger KA. Prevalence of Alzheimer lesions in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1207-8. PMID 14534932 DOI: 10.1002/Mds.10513 |
0.387 |
|
| 2003 |
Jellinger KA, Mitter-Ferstl E. The impact of cerebrovascular lesions in Alzheimer disease--a comparative autopsy study. Journal of Neurology. 250: 1050-5. PMID 14504965 DOI: 10.1007/S00415-003-0142-0 |
0.452 |
|
| 2003 |
Jellinger KA. Neuropathological spectrum of synucleinopathies. Movement Disorders : Official Journal of the Movement Disorder Society. 18: S2-12. PMID 14502650 DOI: 10.1002/Mds.10557 |
0.374 |
|
| 2003 |
Rauschka H, Jellinger K, Lassmann H, Braier F, Schmidbauer M. Guillain-Barré syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnoses. European Journal of Neurology. 10: 479-486. PMID 12940826 DOI: 10.1046/J.1468-1331.2003.00644.X |
0.315 |
|
| 2003 |
Jellinger KA. Is Alzheimer's disease a vascular disorder? Journal of Alzheimer's Disease : Jad. 5: 247-50; discussion 2. PMID 12897409 DOI: 10.3233/Jad-2003-5308 |
0.372 |
|
| 2003 |
Jellinger KA. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study. Acta Neuropathologica. 106: 191-201. PMID 12845452 DOI: 10.1007/S00401-003-0725-Y |
0.417 |
|
| 2003 |
Jellinger KA, Seppi K, Wenning GK. Clinical and neuropathological correlates of Lewy body disease. Acta Neuropathologica. 106: 188-9; author reply . PMID 12783247 DOI: 10.1007/S00401-003-0721-2 |
0.333 |
|
| 2003 |
Lassmann H, Reindl M, Rauschka H, Berger J, Aboul-Enein F, Berger T, Zurbriggen A, Lutterotti A, Brück W, Weber JR, Ullrich R, Schmidbauer M, Jellinger K, Vandevelde M. A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions. Brain : a Journal of Neurology. 126: 1347-57. PMID 12764056 DOI: 10.1093/Brain/Awg127 |
0.317 |
|
| 2003 |
Jellinger KA. Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study. Acta Neuropathologica. 105: 415-9. PMID 12677440 DOI: 10.1007/S00401-003-0676-3 |
0.326 |
|
| 2003 |
Deckert J, Brenner M, Durany N, Zöchling R, Paulus W, Ransmayr G, Tatschner T, Danielczyk W, Jellinger K, Riederer P. Up-regulation of striatal adenosine A(2A) receptors in schizophrenia. Neuroreport. 14: 313-6. PMID 12634474 DOI: 10.1097/00001756-200303030-00003 |
0.385 |
|
| 2003 |
Jellinger KA, Seppi K, Wenning GK. Neuropathologic changes in Parkinson disease with late onset of dementia. Archives of Neurology. 60: 452-3; author reply . PMID 12633162 DOI: 10.1001/Archneur.60.3.452-A |
0.404 |
|
| 2003 |
Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Brück W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases Journal of Neuropathology and Experimental Neurology. 62: 25-33. PMID 12528815 DOI: 10.1093/Jnen/62.1.25 |
0.301 |
|
| 2003 |
Jellinger KA, Attems J. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathologica. 105: 14-7. PMID 12471455 DOI: 10.1007/S00401-002-0634-5 |
0.667 |
|
| 2002 |
Kienzl E, Jellinger K, Janetzky B, Steindl H, Bergmann J. A broader horizon of Alzheimer pathogenesis: ALZAS--an early serum biomarker? Journal of Neural Transmission-Supplement. 87-95. PMID 12456054 DOI: 10.1007/978-3-7091-6139-5_9 |
0.387 |
|
| 2002 |
Jellinger KA, Seppi K, Wenning GK. Lewy bodies in patients presenting clinically with Alzheimer disease. Journal of Alzheimer's Disease : Jad. 4: 327-8. PMID 12446935 DOI: 10.3233/Jad-2002-4408 |
0.46 |
|
| 2002 |
Jellinger KA. The pathology of ischemic-vascular dementia: an update. Journal of the Neurological Sciences. 203: 153-7. PMID 12417375 DOI: 10.1016/S0022-510X(02)00282-4 |
0.43 |
|
| 2002 |
Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 813-36. PMID 12111471 DOI: 10.1007/s007020200068 |
0.325 |
|
| 2002 |
Bergmann J, Kienzl E, Janetzky B, Preddie E, Jellinger KA. Alternatives to the suspended Alzheimer's disease vaccine. Acta Neuropathologica. 104: 111-2. PMID 12070673 DOI: 10.1007/S00401-002-0573-1 |
0.312 |
|
| 2002 |
Götz ME, Wacker M, Luckhaus C, Wanek P, Tatschner T, Jellinger K, Leblhuber F, Ransmayr G, Riederer P, Eder E. Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease. Neuroscience Letters. 324: 49-52. PMID 11983292 DOI: 10.1016/S0304-3940(02)00163-5 |
0.416 |
|
| 2002 |
Jellinger KA, Seppi K, Wenning GK, Poewe W. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 329-39. PMID 11956955 DOI: 10.1007/S007020200027 |
0.413 |
|
| 2002 |
Wenning GK, Seppi K, Tison F, Jellinger K. A novel grading scale for striatonigral degeneration (multiple system atrophy). Journal of Neural Transmission (Vienna, Austria : 1996). 109: 307-20. PMID 11956953 DOI: 10.1007/S007020200025 |
0.317 |
|
| 2002 |
Jellinger KA. Disturbance of the nigro-amygdaloid connections in dementia with Lewy bodies. Journal of the Neurological Sciences. 193: 157-8. PMID 11790397 DOI: 10.1016/S0022-510X(01)00660-8 |
0.322 |
|
| 2002 |
Laich A, Leblhuber F, Widner B, Frick B, Jellinger K, Fuchs D. Moderate Hyperhomocysteinemia in Patients with Huntington's Disease Pteridines. 13: 121-125. DOI: 10.1515/Pteridines.2002.13.4.121 |
0.342 |
|
| 2002 |
Rosler N, Wichart I, Jellinger KA. Aktuelle klinisch-neurochemische Diagnostik derAlzheimer-Krankheit. Current Clinical Neurochemical Diagnosis of Alzheimer's Disease Laboratoriums Medizin. 26: 139-148. DOI: 10.1515/Labmed.2002.019 |
0.382 |
|
| 2001 |
Jellinger KA, Stadelmann C. Problems of cell death in neurodegeneration and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 3: 31-40. PMID 12214070 DOI: 10.3233/Jad-2001-3106 |
0.388 |
|
| 2001 |
Jellinger KA, Paulus W, Wrocklage C, Litvan I. Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 8: 707-10. PMID 11784357 DOI: 10.1046/J.1468-1331.2001.00322.X |
0.599 |
|
| 2001 |
Jellinger K, Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB. Frequency of "dementia of unknown etiology" increases with age [1] (multiple letters) Archives of Neurology. 58: 1498-1499. PMID 11559329 DOI: 10.1001/Archneur.58.9.1498 |
0.313 |
|
| 2001 |
Jellinger KA, Paulus W, Wrocklage C, Litvan I. Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. Bmc Neurology. 1: 3. PMID 11504565 DOI: 10.1186/1471-2377-1-3 |
0.592 |
|
| 2001 |
Jellinger K, Vinters HV, Ellis WG, Jagust WJ, Zarow C, Zaias BW, Chui HC, Mack WJ. Letter to the editor (multiple letters) Journal of Neuropathology and Experimental Neurology. 60: 658-659. PMID 11398842 DOI: 10.1093/Jnen/60.6.658 |
0.394 |
|
| 2001 |
Rösler N, Wichart I, Jellinger KA. Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 231-46. PMID 11314776 DOI: 10.1007/S007020170091 |
0.403 |
|
| 2001 |
Jellinger KA. Small concomitant cerebrovascular lesions are not important for cognitive decline in severe Alzheimer disease. Archives of Neurology. 58: 520-1. PMID 11255466 DOI: 10.1001/Archneur.58.3.520 |
0.374 |
|
| 2001 |
Rösler N, Wichart I, Jellinger KA. Intra vitam lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin-6 in Alzheimer's disease patients. Acta Neurologica Scandinavica. 103: 126-30. PMID 11227132 DOI: 10.1034/J.1600-0404.2001.103002126.X |
0.396 |
|
| 2001 |
Müller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K, Poewe W, Litvan I. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders Archives of Neurology. 58: 259-264. PMID 11176964 DOI: 10.1001/Archneur.58.2.259 |
0.381 |
|
| 2001 |
Rösler N, Wichart I, Jellinger KA. Ex vivo lumbar and post mortem ventricular cerebrospinal fluid substance P-immunoreactivity in Alzheimer's disease patients. Neuroscience Letters. 299: 117-20. PMID 11166952 DOI: 10.1016/S0304-3940(01)01514-2 |
0.407 |
|
| 2001 |
Ransmayr G, Wenning GK, Seppi K, Jellinger K, Poewe W. [Dementia with Lewy bodies]. Der Nervenarzt. 71: 929-35. PMID 11139988 DOI: 10.1007/S001150050689 |
0.418 |
|
| 2001 |
Rösler N, Wichart I, Jellinger KA. CSF Aβ40 and Aβ42: Natural course and clinical usefulness Journal of Alzheimer's Disease. 3: 599-600. DOI: 10.3233/Jad-2001-3611 |
0.335 |
|
| 2000 |
Haberler C, Alesch F, Mazal PR, Pilz P, Jellinger K, Pinter MM, Hainfellner JA, Budka H. No tissue damage by chronic deep brain stimulation in Parkinson's disease. Annals of Neurology. 48: 372-6. PMID 10976644 DOI: 10.1002/1531-8249(200009)48:3<372::Aid-Ana12>3.0.Co;2-0 |
0.329 |
|
| 2000 |
Marksteiner J, Lechner T, Kaufmann WA, Gurka P, Humpel C, Nowakowski C, Maier H, Jellinger KA. Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease. Acta Neuropathologica. 100: 205-12. PMID 10963369 DOI: 10.1007/S004010000239 |
0.322 |
|
| 2000 |
Durany N, Zöchling R, Boissl KW, Paulus W, Ransmayr G, Tatschner T, Danielczyk W, Jellinger K, Deckert J, Riederer P. Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome. Neuroscience Letters. 287: 109-12. PMID 10854724 DOI: 10.1016/S0304-3940(00)01144-7 |
0.395 |
|
| 2000 |
Jellinger KA. Alterations of muscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: relation to Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 68: 253-4. PMID 10702044 DOI: 10.1136/Jnnp.68.2.253 |
0.395 |
|
| 2000 |
Jellinger KA. Pathology of Parkinsonism Neurobiology of Aging. 21: 135. DOI: 10.1016/S0197-4580(00)82406-9 |
0.357 |
|
| 1999 |
Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, Poewe W, Litvan I. Progression of falls in postmortem-confirmed parkinsonian disorders Movement Disorders. 14: 947-950. PMID 10584668 DOI: 10.1002/1531-8257(199911)14:6<947::Aid-Mds1006>3.0.Co;2-O |
0.344 |
|
| 1999 |
Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Brück W, Jellinger K, Lassmann H. Activation of Caspase-3 in Single Neurons and Autophagic Granules of Granulovacuolar Degeneration in Alzheimer’s Disease : Evidence for Apoptotic Cell Death American Journal of Pathology. 155: 1459-1466. PMID 10550301 DOI: 10.1016/S0002-9440(10)65460-0 |
0.343 |
|
| 1999 |
Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, Verny M, Jellinger K, Chaudhuri KR, Pearce RK. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration Journal of Neurology. 246: II1-5. PMID 10525996 DOI: 10.1007/Bf03161075 |
0.36 |
|
| 1999 |
Wenning GK, Scherfler C, Granata R, Bösch S, Verny M, Chaudhuri KR, Jellinger K, Poewe W, Litvan I. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: A clinicopathological study Journal of Neurology Neurosurgery and Psychiatry. 67: 620-623. PMID 10519868 DOI: 10.1136/Jnnp.67.5.620 |
0.352 |
|
| 1999 |
Paulus W, Jellinger KA. Citation analysis of neuropathology journals. Acta Neuropathologica. 97: 323-6. PMID 10208270 DOI: 10.1007/S004010050993 |
0.419 |
|
| 1999 |
Almer G, Hainfellner JA, Brücke T, Jellinger K, Kleinert R, Bayer G, Windl O, Kretzschmar HA, Hill A, Sidle K, Collinge J, Budka H. Fatal familial insomnia: a new Austrian family. Brain : a Journal of Neurology. 122: 5-16. PMID 10050890 DOI: 10.1093/Brain/122.1.5 |
0.348 |
|
| 1999 |
Jellinger KA, Gabriel E. No increased incidence of Alzheimer's disease in elderly schizophrenics. Acta Neuropathologica. 97: 165-9. PMID 9928827 |
0.329 |
|
| 1998 |
Litvan I, Jankovic J, Goetz CG, Wenning GK, Sastry N, Jellinger K, McKee A, Lai EC, Brandel JP, Verny M, Ray-Chaudhuri K, Pearce RK, Bartko JJ, Agid Y. Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 5: 451-457. PMID 10210873 DOI: 10.1046/J.1468-1331.1998.550451.X |
0.335 |
|
| 1998 |
Jellinger KA, Bancher C. Neuropathology of Alzheimer's disease: a critical update. Journal of Neural Transmission. Supplementum. 54: 77-95. PMID 9850917 DOI: 10.1007/978-3-7091-7508-8_8 |
0.439 |
|
| 1998 |
Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathologica. 96: 116-22. PMID 9705125 DOI: 10.1007/S004010050870 |
0.435 |
|
| 1998 |
Bancher C, Jellinger K, Wichart I. Biological markers for the diagnosis of Alzheimer's disease. Journal of Neural Transmission. Supplementum. 53: 185-97. PMID 9700657 DOI: 10.1007/978-3-7091-6467-9_17 |
0.446 |
|
| 1998 |
Jellinger KA. The neuropathological diagnosis of Alzheimer disease. Journal of Neural Transmission. Supplementum. 53: 97-118. PMID 9700649 |
0.306 |
|
| 1998 |
Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Archives of Neurology. 55: 969-78. PMID 9678315 DOI: 10.1001/Archneur.55.7.969 |
0.373 |
|
| 1998 |
Litvan I, Booth V, Wenning GK, Bartko JJ, Goetz CG, McKee A, Jankovic J, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 217-27. PMID 9660099 DOI: 10.1007/S007020050050 |
0.301 |
|
| 1998 |
Stadelmann C, Brück W, Bancher C, Jellinger K, Lassmann H. Alzheimer Disease: DNA Fragmentation Indicates Increased Neuronal Vulnerability, but not Apoptosis Journal of Neuropathology and Experimental Neurology. 57: 456-464. PMID 9596416 DOI: 10.1097/00005072-199805000-00009 |
0.338 |
|
| 1998 |
Jellinger KA. Dementia with grains (argyrophilic grain disease). Brain Pathology (Zurich, Switzerland). 8: 377-86. PMID 9546294 DOI: 10.1111/J.1750-3639.1998.Tb00161.X |
0.41 |
|
| 1998 |
Jellinger KA, Bancher C. Senile dementia with tangles (tangle predominant form of senile dementia). Brain Pathology (Zurich, Switzerland). 8: 367-76. PMID 9546293 DOI: 10.1111/J.1750-3639.1998.Tb00160.X |
0.446 |
|
| 1998 |
Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, Poewe W, Jellinger K, Chaudhuri KR, D'Olhaberriague L, Pearce RKB. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination Journal of Neurology Neurosurgery and Psychiatry. 64: 184-189. PMID 9489528 DOI: 10.1136/Jnnp.64.2.184 |
0.354 |
|
| 1997 |
Bancher C, Egensperger R, Kösel S, Jellinger K, Graeber MB. Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathologica. 94: 403-9. PMID 9386771 DOI: 10.1007/S004010050726 |
0.418 |
|
| 1997 |
Jellinger KA, Bancher C. Proposals for re-evaluation of current autopsy criteria for the diagnosis of Alzheimer's disease. Neurobiology of Aging. 18: S55-65. PMID 9330987 |
0.352 |
|
| 1997 |
Litvan I, Agid Y, Sastry N, Jankovic J, Wenning GK, Goetz CG, Verny M, Brandel JP, Jellinger K, Chaudhuri KR, McKee A, Lai EC, Pearce RK, Bartko JJ, Sastrj N. What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology. 49: 62-9. PMID 9222171 DOI: 10.1212/Wnl.49.1.62 |
0.399 |
|
| 1997 |
Bancher C, Lassmann H, Breitschopf H, Jellinger KA. Mechanisms of cell death in Alzheimer's disease. Journal of Neural Transmission. Supplementum. 50: 141-52. PMID 9120414 DOI: 10.1007/978-3-7091-6842-4_14 |
0.351 |
|
| 1997 |
Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RKB, D'Olhaberriague L. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study Brain. 120: 65-74. PMID 9055798 DOI: 10.1093/Brain/120.1.65 |
0.37 |
|
| 1997 |
Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RKB, Bartko JJ. Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study Neurology. 48: 119-125. PMID 9008506 DOI: 10.1212/Wnl.48.1.119 |
0.345 |
|
| 1997 |
Jellinger K, Bancher C, Egensperger R, Kösel S, Graeber MB. ABSENCE OF APOE ϵ4 ALLELE IN THE NEUROFIBRILLARY TANGLE SUBSET OF SENILE DEMENTIA Journal of Neuropathology and Experimental Neurology. 56: 572. DOI: 10.1097/00005072-199705000-00018 |
0.363 |
|
| 1997 |
Leblhuber F, Trenkler J, Walli J, Bancher C, Jellinger K. 5-07-16 Cerebral amyloid angiopathy in Alzheimer's disease: Computer tomographic and neuropathological findings Journal of the Neurological Sciences. 150. DOI: 10.1016/S0022-510X(97)86248-X |
0.43 |
|
| 1996 |
Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathologica. 91: 427-31. PMID 8928621 DOI: 10.1007/S004010050446 |
0.348 |
|
| 1996 |
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, ... ... Jellinger KA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47: 1113-24. PMID 8909416 DOI: 10.1212/Wnl.47.5.1113 |
0.456 |
|
| 1996 |
Rösler N, Wichart I, Bancher C, Jellinger KA. Tau protein and apolipoprotein E in CSF diagnostics of Alzheimer's disease: impact on non Alzheimer's dementia? Journal of Neural Transmission. Supplementum. 47: 259-66. PMID 8841971 DOI: 10.1007/978-3-7091-6892-9_18 |
0.419 |
|
| 1996 |
Bancher C, Leitner H, Jellinger K, Eder H, Setinek U, Fischer P, Wegiel J, Wisniewski HM. On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis. Neurobiology of Aging. 17: 527-33. PMID 8832626 DOI: 10.1016/0197-4580(96)00069-3 |
0.366 |
|
| 1996 |
Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri KR, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RKB. Accuracy of Clinical Criteria for the Diagnosis of Progressive Supranuclear Palsy (Steele-Richardson-Olszewski Syndrome) Neurology. 46: 922-930. PMID 8780065 DOI: 10.1212/Wnl.46.4.922 |
0.399 |
|
| 1996 |
Rösler N, Wichart I, Jellinger KA. Intra vitam lumbar cerebrospinal fluid and serum and postmortem ventricular immunoreactive apolipoprotein E in patients with Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 60: 452-4. PMID 8774418 DOI: 10.1136/Jnnp.60.4.452 |
0.401 |
|
| 1996 |
Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F. Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia. European Archives of Psychiatry and Clinical Neuroscience. 246: 137-146. PMID 8739399 DOI: 10.1007/Bf02189115 |
0.442 |
|
| 1996 |
Hainfellner JA, Jellinger K, Diringer H, Guentchev M, Kleinert R, Pilz P, Maier H, Budka H. Creutzfeldt-Jakob disease in Austria. Journal of Neurology, Neurosurgery, and Psychiatry. 61: 139-42. PMID 8708680 DOI: 10.1136/Jnnp.61.2.139 |
0.343 |
|
| 1996 |
Rösler N, Wichart I, Jellinger KA. Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 60: 237-8. PMID 8708672 DOI: 10.1136/Jnnp.60.2.237-A |
0.386 |
|
| 1996 |
Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, D'Olhaberriague L, Chaudhuri KR, Pearce RK. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. Journal of Neurology, Neurosurgery, and Psychiatry. 60: 615-620. PMID 8648326 DOI: 10.1136/Jnnp.60.6.615 |
0.331 |
|
| 1996 |
Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. Journal of Neuropathology and Experimental Neurology. 55: 97-105. PMID 8558176 DOI: 10.1097/00005072-199601000-00010 |
0.341 |
|
| 1996 |
Budka H, Hainfellner JA, Guentchev M, Jellinger K, Diringer H, Gullotta F, Kleinert R, Pilz P, Maier H, Pietrini V, Trabattoni GR. NEUROPATHOLOGICALLY CONFIRMED SPORADIC CREUTZFELDT-JAKOB DISEASE Journal of Neuropathology and Experimental Neurology. 55: 661. DOI: 10.1097/00005072-199605000-00233 |
0.364 |
|
| 1996 |
Egensperger R, Bancher C, Kösel S, Jellinger K, Mehraein P, Graeber MB. 752 The apolipoprotein E e4 allele in Parkinson disease with and without Alzheimer lesions Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80754-8 |
0.333 |
|
| 1996 |
Budka H, Hainfellner JA, Jellinger K, Gullotta F. 469 Combination of Alzheimer's disease with Creutzfeldt-Jakob disease: A neuropathological study Neurobiology of Aging. 17. DOI: 10.1016/S0197-4580(96)80471-4 |
0.392 |
|
| 1995 |
Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Gullotta F, Haltia M, Hauw JJ, Ironside JW, Jellinger K. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathology (Zurich, Switzerland). 5: 459-66. PMID 8974629 DOI: 10.1111/J.1750-3639.1995.Tb00625.X |
0.384 |
|
| 1995 |
Jellinger KA, Paulus W. Primary central nervous system lymphomas--new pathological developments. Journal of Neuro-Oncology. 24: 33-6. PMID 8523072 |
0.359 |
|
| 1995 |
Gsell W, Conrad R, Hickethier M, Sofic E, Frölich L, Wichart I, Jellinger K, Moll G, Ransmayr G, Beckmann H. Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. Journal of Neurochemistry. 64: 1216-23. PMID 7861154 DOI: 10.1046/J.1471-4159.1995.64031216.X |
0.317 |
|
| 1995 |
Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathologica. 89: 35-41. PMID 7709729 DOI: 10.1007/Bf00294257 |
0.378 |
|
| 1994 |
Paulus W, Bancher C, Jellinger K. Microglial reaction in Pick's disease. Neuroscience Letters. 161: 89-92. PMID 8255555 DOI: 10.1016/0304-3940(93)90147-D |
0.503 |
|
| 1994 |
Paulus W, Jellinger KA. A case of primary central nervous system lymphoma (PCNSL) of putative T-cell lineage. Journal of Neuro-Oncology. 18: 83-4. PMID 8057138 DOI: 10.1007/BF01324607 |
0.318 |
|
| 1994 |
Bancher C, Jellinger KA. Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects. Acta Neuropathologica. 88: 565-70. PMID 7879604 DOI: 10.1007/Bf00296494 |
0.461 |
|
| 1994 |
Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J, Jellinger K. Amygdala pathology in Parkinson's disease. Acta Neuropathologica. 88: 493-500. PMID 7879596 DOI: 10.1007/Bf00296485 |
0.331 |
|
| 1994 |
Jellinger K, Paulus W. Mesenchymal, non-meningothelial tumors of the central nervous system. Brain Pathology (Zurich, Switzerland). 1: 79-87. PMID 1669699 DOI: 10.1111/J.1750-3639.1991.Tb00643.X |
0.403 |
|
| 1994 |
Braak H, Jellinger K. Workshop 13: Non-Alzheimer's Dementia Brain Pathology. 4: 343-345. DOI: 10.1111/J.1750-3639.1994.Tb00922.X |
0.387 |
|
| 1994 |
Bancher C, Paulus W, Paukner K, Jellinger K. A questionnaire on the neuropathological diagnosis of Alzheimer disease in German-speaking countries: Consensus between practicing neuropathologists? Neurobiology of Aging. 15: S99. DOI: 10.1016/0197-4580(94)92859-2 |
0.548 |
|
| 1993 |
Jellinger KA, Kienzl E, Rumpelmaier G, Paulus W, Riederer P, Stachelberger H, Youdim MB, Ben-Shachar D. Iron and ferritin in substantia nigra in Parkinson's disease. Advances in Neurology. 60: 267-72. PMID 8420142 |
0.363 |
|
| 1993 |
Lassmann H, Fischer P, Jellinger K. Synaptic Pathology Of Alzheimer’S Disease Annals of the New York Academy of Sciences. 695: 59-64. PMID 8239314 DOI: 10.1111/J.1749-6632.1993.Tb23028.X |
0.363 |
|
| 1993 |
Bancher C, Braak H, Fischer P, Jellinger KA. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neuroscience Letters. 162: 179-82. PMID 8121624 DOI: 10.1016/0304-3940(93)90590-H |
0.45 |
|
| 1992 |
Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. Journal of Neuropathology and Experimental Neurology. 50: 743-55. PMID 1748881 DOI: 10.1097/00005072-199111000-00006 |
0.51 |
|
| 1992 |
Paulus W, Bancher C, Jellinger K. Interrater reliability in the neuropathologic diagnosis of Alzheimer's disease Neurology. 42: 329-329. PMID 1736160 DOI: 10.1212/Wnl.42.2.329 |
0.545 |
|
| 1992 |
Lassmann H, Weiler R, Fischer P, Bancher C, Jellinger K, Floor E, Danielczyk W, Seitelberger F, Winkler H. Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles. Neuroscience. 46: 1-8. PMID 1594095 DOI: 10.1016/0306-4522(92)90003-K |
0.616 |
|
| 1992 |
Riederer P, Dirr A, Goetz M, Sofic E, Jellinger K, Youdimt MBH. Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease Annals of Neurology. 32. PMID 1510366 DOI: 10.1002/Ana.410320717 |
0.307 |
|
| 1992 |
Braak H, Jellinger K, Braak E, Bohl J. Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathologica. 84: 478-83. PMID 1462762 DOI: 10.1007/Bf00304466 |
0.388 |
|
| 1992 |
Jellinger KA, Paulus W. Primary central nervous system lymphomas--an update. Journal of Cancer Research and Clinical Oncology. 119: 7-27. PMID 1400570 DOI: 10.1007/Bf01209483 |
0.448 |
|
| 1992 |
Jellinger KA, Paulus W. Clinico-pathological correlations in Parkinson's disease. Clinical Neurology and Neurosurgery. 94: S86-8. PMID 1320531 DOI: 10.1016/0303-8467(92)90033-Y |
0.485 |
|
| 1992 |
Götz ME, Freyberger A, Hauer E, Burger R, Sofic E, Gsell W, Heckers S, Jellinger K, Hebenstreit G, Frölich L, Beckmann H, Riederer P. Susceptibility of brains from patients with alzheimer's disease to oxygen-stimulated lipid peroxidation and differential scanning calorimetry Dementia and Geriatric Cognitive Disorders. 3: 213-222. DOI: 10.1159/000107020 |
0.305 |
|
| 1991 |
Paulus W, Jellinger K, Perneczky G. Intraspinal neurothekeoma (nerve sheath myxoma). A report of two cases. American Journal of Clinical Pathology. 95: 511-6. PMID 2014778 DOI: 10.1093/Ajcp/95.4.511 |
0.412 |
|
| 1991 |
Lestienne P, Nelson I, Riederer P, Reichmann H, Jellinger K. Mitochondrial DNA in postmortem brain from patients with Parkinson's disease. Journal of Neurochemistry. 56: 1819-1819. PMID 2013767 DOI: 10.1111/J.1471-4159.1991.Tb02087.X |
0.31 |
|
| 1991 |
Fischer P, Jellinger K, Gatterer G, Danielczyk W. Prospective neuropathological validation of Hachinski's Ischaemic Score in dementias. Journal of Neurology, Neurosurgery, and Psychiatry. 54: 580-583. PMID 1895120 DOI: 10.1136/Jnnp.54.7.580 |
0.406 |
|
| 1991 |
Jellinger K, Braak H, Braak E, Fischer P. Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Annals of the New York Academy of Sciences. 640: 203-9. PMID 1776740 DOI: 10.1111/J.1749-6632.1991.Tb00218.X |
0.429 |
|
| 1991 |
Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MBH. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. Journal of Neurochemistry. 56: 978-982. PMID 1704426 DOI: 10.1111/J.1471-4159.1991.Tb02017.X |
0.415 |
|
| 1991 |
Sofic E, Frölich L, Riederer P, Jellinger K, Heckers S, Beckmann H, Deinzer E, Pantucek F, Hebenstreit G, Ransmayr G. Biochemical Membrane Constituents and Activities of Alkaline and Acid Phosphatase and Cathepsin in Cortical and Subcortical Brain Areas in Dementia of the Alzheimer Type Dementia and Geriatric Cognitive Disorders. 2: 39-44. DOI: 10.1159/000107173 |
0.369 |
|
| 1990 |
Jellinger K, Danielczyk W, Fischer P, Gabriel E. Clinicopathological analysis of dementia disorders in the elderly Journal of the Neurological Sciences. 95: 239-258. PMID 2358819 DOI: 10.1016/0022-510X(90)90072-U |
0.433 |
|
| 1990 |
Jellinger K. Neuropathological substrate of dementia in Parkinson's disease. Annals of Neurology. 28: 723-724. PMID 2260863 DOI: 10.1002/Ana.410280522 |
0.393 |
|
| 1989 |
Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Research. 477: 90-9. PMID 2495152 DOI: 10.1016/0006-8993(89)91396-6 |
0.67 |
|
| 1989 |
Bancher C, Lassmann H, Budka H, Jellinger K, Grundke-Iqbal I, Iqbal K, Wiche G, Seitelberger F, Wisniewski HM. An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. Journal of Neuropathology and Experimental Neurology. 48: 81-93. PMID 2462024 DOI: 10.1097/00005072-198901000-00007 |
0.54 |
|
| 1989 |
Jellinger K, Gabriel E, Danielczvk W, Boltzmann L. CLINICOPATHOLOGICAL ANALYSIS OF DEMENTIA DISORDERS IN THE AGED Journal of Neuropathology and Experimental Neurology. 48: 379. DOI: 10.1097/00005072-198905000-00240 |
0.319 |
|
| 1988 |
Jellinger K. Quantitative changes in some subcortical nuclei in aging, Alzheimer's disease and Parkinson's disease. Neurobiology of Aging. 8: 556-61. PMID 3323929 DOI: 10.1016/0197-4580(87)90134-5 |
0.415 |
|
| 1978 |
Kothbauer P, Jellinger K, Gross H, Molzer B, Bernheimer H. [Adult metachromatic leukodystrophy manifested as schizophrenic psychosis (author's transl)]. Archiv Fur Psychiatrie Und Nervenkrankheiten. 224: 379-87. PMID 606208 DOI: 10.1007/Bf00341619 |
0.308 |
|
| 1977 |
Jellinger K. Cerebrovascular Amyloidosis with Cerebral Hemorrhage Journal of Neurology. 214: 195-206. PMID 65454 DOI: 10.1007/Bf00316150 |
0.406 |
|
| 1974 |
Jellinger K, Heiss WD, Deisenhammer E. The ataxic (cerebellar) form of Creutzfeldt-Jakob disease. Journal of Neurology. 207: 289-305. PMID 4138140 DOI: 10.1007/Bf00312583 |
0.386 |
|
| 1973 |
Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. Journal of the Neurological Sciences. 20: 415-55. PMID 4272516 DOI: 10.1016/0022-510X(73)90175-5 |
0.574 |
|
| 1971 |
Jellinger K. Progressive supranuclear palsy (subcortical argyrophilic dystrophy). Acta Neuropathologica. 19: 347-352. PMID 5143983 DOI: 10.1007/Bf00692156 |
0.408 |
|
| 1971 |
Jellinger K, Seitelberger F, Kozik M. Perivascular accumulation of lipids in the infant human brain. Acta Neuropathologica. 19: 331-42. PMID 5143982 DOI: 10.1007/Bf00692154 |
0.571 |
|
| 1970 |
Jellinger K. Neuropathological aspects of hypsarrhythmia. Neuropediatrics. 1: 277-294. PMID 5538097 DOI: 10.1055/S-0028-1091819 |
0.316 |
|
| 1970 |
Jellinger K, Seitelberger F. Spongy glio-neuronal dystrophy in infancy and childhood. Acta Neuropathologica. 16: 125-40. PMID 5473464 DOI: 10.1007/Bf00687667 |
0.592 |
|
| 1970 |
Jellinger K, Seitelberger F. Protracted post-traumatic encephalopathy. Pathology, pathogenesis and clinical implications. Journal of the Neurological Sciences. 10: 51-94. PMID 5411990 DOI: 10.1016/0022-510X(70)90091-2 |
0.587 |
|
| 1969 |
Jellinger K, Seitelberger F. Juvenile form of spongy degeneration of the CNS. Acta Neuropathologica. 13: 276-81. PMID 5805977 DOI: 10.1007/Bf00690647 |
0.555 |
|
| 1969 |
Jellinger K, Seitelberger F. Pelizacus-Merzbacher disease. Transitional form between classical and co-natal (Seitelberger) type. Acta Neuropathologica. 14: 108-17. PMID 5347059 DOI: 10.1007/Bf00686347 |
0.578 |
|
| 1968 |
Gross H, Jellinger K, Kaltenbäck E, Rett A. Infantile cerebral disorders. Clinical-neuropathological correlations to elucidate the aetiological factors. Journal of the Neurological Sciences. 7: 551-564. PMID 5751522 DOI: 10.1016/0022-510X(68)90060-9 |
0.339 |
|
| 1967 |
Jellinger K, Seitelberger F. [Pseudosystemic lesions in "atypical" encephalitides]. Acta Neuropathologica. 8: 185-209. PMID 6033098 DOI: 10.1007/Bf00687695 |
0.513 |
|
| 1965 |
Jellinger K, Seitelberger F. Beitrag zur „progressiven multifokalen Leukoencephalopathie“ Journal of Neurology. 187: 749-769. DOI: 10.1007/Bf00242492 |
0.498 |
|
| 1964 |
JELLINGER K, POETSCH F, SEITELBERGER F. [ACUTE NECROTIZING INCLUSION BODY ENCEPHALITIS. ISOLATION OF HERPES SIMPLEX VIRUS FROM THE BRAIN]. Acta Neuropathologica. 3: 278-83. PMID 14191004 DOI: 10.1007/Bf00684403 |
0.523 |
|
| 1963 |
Jellinger K, Seitelberger F. On the problem of central nervous complications following rabies vaccination Journal of Neurology. 184: 508-536. DOI: 10.1007/Bf00244100 |
0.494 |
|
| Show low-probability matches. |
